- Approval Id
- 8a3ed8cf0631df36
- Drug Name
- Neulastim Pre-filled Syringe 6mg/0.6ml
- Product Name
- Neulastim Pre-filled Syringe 6mg/0.6ml
- Approval Number
- SIN13200P
- Approval Date
- 2006-04-20
- Registrant
- AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
- Licence Holder
- AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION, SOLUTION
- Dosage
- **2.2 Dosage and Administration**
Adults (≥ 18 years): One 6 mg dose (a single pre-filled syringe) of pegfilgrastim is recommended for each chemotherapy cycle, administered as a subcutaneous injection approximately 24 hours following cytotoxic chemotherapy.
Neulastim therapy should be initiated and supervised by physicians experienced in oncology and/or haematology.
- Route Of Administration
- SUBCUTANEOUS
- Indication Info
- **2.1 Therapeutic Indication(s)**
Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
- Contraindications
- **2.3 Contraindications**
Hypersensitivity to the active substance or to any of the excipients listed in section 1.5 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
- Atc Code
- L03AA13
- Atc Item Name
- pegfilgrastim
- Pharma Manufacturer Name
- AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.
- Company Detail Path
- /organization/amgen-biotechnology-singapore-pte-ltd
